We will try to observe whether the Tau hyperphosphorylation sites in different models are consistent with the Tau hyperphosphorylation sites induced by CUMS and detect the sites of Tau hyperphosphorylation in cerebrospinal fluid of patients who have clinical depression with different degrees of severity. Here, MAPT is linked to major depressive disorder.